Nassau County drug rehab now offers monthly Sublocade and Vivitrol injections for opioid and alcohol addiction on Long ...
A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.
Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly ...
March 22, 2026 – National Institutes of Health (NIH) released the following: ...
Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.
Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm ...
Please provide your email address to receive an email when new articles are posted on . The study included 227 individuals with OUD given CAM2038 either on weekly or monthly basis. The treatment was ...
Audacy on MSN
Cooper University Hospital first in the nation to equip EMS with injectable that treats opioid overdose
Cooper University Hospital paramedics are the first in the nation to carry an injectable form of a drug that treats opioid ...
The US Food and Drug Administration (FDA) has approved extended-release injection buprenorphine (Brixadi, Braeburn Inc) for the treatment of moderate to severe opioid use disorder (OUD). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results